Objective: The objective of this study was to evaluate outcomes of directional branches using self-expandable stent grafts (SESGs) or balloon-expandable stent grafts (BESGs) during fenestrated-branched endovascular aneurysm repair of thoracoabdominal aortic aneurysms.
Objective: The objective of this study was to evaluate outcomes of directional branches using self-expandable stent grafts (SESGs) or balloon-expandable stent grafts (BESGs) during fenestrated-branched endovascular aneurysm repair of thoracoabdominal aortic aneurysms.
Methods: Patients treated with fenestrated-branched endovascular aneurysm repair in a prospective study using directional branches were included in the study. Choice of bridging stent evolved from SESG to BESG (Gore VBX; W. L. Gore & Associates, Flagstaff, Ariz) in February 2017. Target artery instability (TAI) was defined by stent occlusion, stenosis, separation, type IC or type IIIC endoleak, reintervention, rupture, or death due to target artery complication. End points included technical success; target artery patency; and freedom from TAI, type IC or type IIIC endoleak, and reintervention.
Results: There were 118 patients (60% male; mean age, 75 6 7 years) with 296 renal-mesenteric arteries targeted by directional branches using SESGs in 69 patients/162 arteries or BESGs in 49 patients/134 arteries. Patients in both groups had similar aneurysm diameter, target artery diameter, and thoracoabdominal aortic aneurysm extent, which was I to III in 90%. Patients treated by SESGs had significantly (P < .05) shorter stent length (À7 mm), larger stent diameter (+1 mm), and more adjunctive bare-metal stents (74% vs 10%). Technical success was achieved in all patients, with no 30-day mortality. Mean follow-up was significantly longer among patients treated by SESGs (19 6 12 months vs 6 6 5 months). TAI occurred in 19 directional branches (6%), including 2 stent occlusions (all SESGs), 5 stenoses (3 SESGs, 2 BESGs), 2 separations (all SESGs), 9 type IC endoleaks (2 SESGs, 7 BESGs), and 4 type IIIC endoleaks (3 SESGs, 1 BESG), resulting in 15 reinterventions. At 1 year, there was no difference in primary (97% 6 1% vs 98% 6 1%; P ¼ .77) and secondary patency (99% 6 1% vs 100%; P ¼ .38) for SESGs and BESGs, respectively. However, SESGs had higher freedom from TAI (96% 6 2% vs 90% 6 4%; P ¼ .005), type IC and type IIIC endoleaks (98% 6 1% vs 91% 6 3%; P ¼ .003), and reinterventions (96% 6 1% vs 92% 6 4%; P ¼ .02) compared with BESGs (Table) . Factors associated with TAI were renal artery target (odds ratio, 2.8; P ¼ .03) and lack of adjunctive bare-metal stents (odds ratio, 0.2; P ¼ .004).
Conclusions: Directional branches were associated with high technical success and low rates of occlusion or stenosis, independent of stent type. However, freedom from TAI was lower for BESGs because of more target artery endoleaks. Objective: Mycotic thoracoabdominal and pararenal aortic aneurysms (mTAAAs/PRAAs) or infections of TAAA and PRAA grafts (iTAAAs/PRAAs) are a rare but devastating clinical problem. Treatment requires complex surgical reconstruction to maintain visceral and renal perfusion. There is a paucity of literature describing outcomes for this technically challenging and highly lethal problem. Herein, we report our experience in the management of these patients.
Methods: Retrospective review was performed for all patients undergoing surgical intervention for mTAAA/iTAAA between 2004 and 2017. The primary end point was in-hospital mortality. Secondary end points included in-hospital complications, reintervention, and reinfection.
Results: Thirty-five patients underwent surgical intervention for mTAAA/iTAAA (mean age, 62 years; male 83%). Twenty patients had mTAAA (70%)/iTAAA (30%; all endografts), and 15 patients had mPRAA (33%)/iPRAA (67%; 60% endografts). Index operation was performed at a referring institution in 88%. Median time from index operation to presentation was 9 months (range, 1-156 months). Presentation was urgent/ emergent for all but one patient, with rupture in 50%. An organism was identified from blood or operative cultures in 24 patients (88% monomicrobial, 12% polymicrobial), most commonly Staphylococcus aureus (46%), Enterococcus (13%), and Candida (13%). Surgical management included graft explantation or excision with in situ rifampin-soaked graft with visceral artery bypass (66%), open visceral debranching followed by thoracic endovascular aortic repair (9%), aortic allograft with visceral artery reimplantation (9%), extra-anatomic bypass with oversewing of aortic stump and antegrade visceral artery bypass (9%), fenestrated endovascular aneurysm repair (3%), or neoaortoiliac system using femoral veins with sacrifice of renal arteries (3%). One death occurred intraoperatively (3%). Major complications included acute renal failure requiring hemodialysis (22%), myocardial infarction (14%), spinal cord ischemia (6%), hemorrhage requiring re-exploration (6%), bowel ischemia requiring resection (3%), seroma evacuation (3%), and chyle leak (3%). Median length of hospital stay was 19 (range, 1-92) days. Reinterventions included graft thrombosis (6%), anastomotic stenosis (6%), aortogastric fistula (3%), surgical site infection (3%), and mycotic aneurysm recurrence requiring visceral aneurysm repair (3%). In-hospital or 30-day mortality was 17%. At median follow-up of 1 month (range, 0-69 months), 60% are alive, with 20% requiring reinterventions and 6% having reinfections. 
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